The funding represents a major endorsement of Docstribe's vision to transform healthcare delivery through technology, precision medicine, and patient-centered care while helping healthcare providers improve clinical outcomes and business performance.
Built on the principle that every patient deserves a personalized and data-driven healthcare journey, Docstribe enables healthcare providers to activate, engage, and monitor patients throughout every stage of care. The platform is designed to shift healthcare systems from reactive treatment models to proactive care delivery by identifying high-risk patients early and enabling timely, targeted clinical intervention.
Supported by extensive clinical expertise and powered by precision medicine, the platform delivers measurable improvements in clinical outcomes, revenue growth, and overall patient experience across multiple healthcare service lines. Its precision care coordination framework extends beyond conventional digital tools by integrating seamlessly across healthcare services, allowing organizations to expand patient care without compromising quality or personalization.
Akash Manu Srivastava, Co-Founder of Docstribe, said the investment from ABGD Ventures validates the company's long-term vision of making precision care coordination accessible to healthcare systems committed to improving patient outcomes. He stated that the funding would accelerate the company's expansion into the United States and the United Arab Emirates, where growing demand for artificial intelligence-driven healthcare solutions presents a significant opportunity to demonstrate the value of AI-powered patient care journeys.
He further said the company is not only expanding its geographical presence but also strengthening its commitment to healthcare providers by building local partnerships, enhancing platform capabilities, and continuing to advance innovation in precision medicine.
Sameer Dashputre, General Partner at ABGD Ventures, said the investment firm focuses on identifying validated healthcare technologies developed in India and scaling them across developed healthcare markets, including the Gulf Cooperation Council countries, the United States, the European Union, and the United Kingdom. He said the healthcare sector has reached a transformational stage, and platforms that successfully combine artificial intelligence, clinical intelligence, and a patient-first approach will shape the future of healthcare delivery. He added that ABGD Ventures is proud to support Docstribe as it expands its vision into international markets.
The United States and the United Arab Emirates have been identified as strategic priorities for Docstribe's next phase of growth because both markets demonstrate strong adoption of healthcare innovation, increasing investment in digital health infrastructure, and a growing transition toward value-based healthcare models.
The company plans to support its international expansion through focused market-entry strategies, strategic partnerships with leading hospitals, healthcare systems, and care networks, while maintaining a dedicated emphasis on delivering measurable clinical and financial outcomes for partner organizations. The funding will also enable Docstribe to establish dedicated local teams in the United States and the United Arab Emirates, strengthen partnerships with hospitals and healthcare providers, and further enhance its platform to meet the specific requirements of each market.
Docstribe is an artificial intelligence-powered digital patient care journey and precision care coordination platform designed to activate, engage, and monitor patients throughout their healthcare experience. By leveraging data-driven precision medicine, the platform helps healthcare providers identify high-risk patients, improve clinical outcomes, increase revenue, and enhance patient experience across healthcare services. The company remains focused on delivering precision care coordination supported by science, technology, and a sustained commitment to improving patient outcomes.
ABGD Ventures is a healthcare technology-focused venture capital fund that invests in validated Indian healthcare technology startups and supports their expansion into international healthcare markets, including the United States, the United Kingdom, the Gulf Cooperation Council countries, and the European Union. Established by experienced healthcare technology operators with expertise in scaling Indian companies into the United States, the firm works closely with founders on clinical validation, regulatory navigation, and international market execution. Guided by its vision of "One World, One Health," ABGD Ventures invests in stage-agnostic healthcare technology companies leveraging artificial intelligence, big data, and emerging technologies to advance clinical and non-clinical healthcare solutions while providing operational expertise, market access, and strategic guidance to achieve sustainable global growth and long-term financial performance.
The strategic investment marks a significant step in Docstribe's international expansion and reinforces growing investor confidence in artificial intelligence-powered healthcare platforms capable of delivering measurable clinical outcomes, stronger healthcare coordination, and sustainable value across global healthcare systems.
About The Author
Comment List